Dolby Laboratories (NYSE:DLB) EVP Mark Andrew Sherman Sells 2,491 Shares of Stock

December 18, 2025 by InsiderTrades.com

Key Points

CEO Kevin Yeaman sold 26,766 shares on December 16 at an average price of $66.74 for about $1.79M, reducing his holding by 20.29% to 105,128 shares (worth roughly $7.02M).
Quarterly earnings beat and guidance: Dolby reported $0.99 EPS vs. $0.70 expected and $307.02M revenue, and issued FY2026 EPS guidance of $4.190–4.340 and Q1 2026 guidance of $0.790–0.940.
Dividend increase and market snapshot: The company raised its quarterly dividend to $0.36 ($1.44 annually, ~2.1% yield); Dolby has a market cap of $6.41B, a P/E of ~25.5 and a 52‑week range of $64.02–$89.66.

Dolby Laboratories (NYSE:DLB - Get Free Report) EVP Mark Andrew Sherman sold 2,491 shares of the stock in a transaction that occurred on Wednesday, December 17th. The shares were sold at an average price of $67.26, for a total transaction of $167,544.66. Following the completion of the sale, the executive vice president owned 70,563 shares in the company, valued at $4,746,067.38. This represents a 3.41% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link.

Big Screen Stock Soars on Blockbuster Q2 Earnings

Mark Andrew Sherman also recently made the following trade(s):

On Tuesday, December 16th, Mark Andrew Sherman sold 9,109 shares of Dolby Laboratories stock. The stock was sold at an average price of $66.73, for a total value of $607,843.57.
On Monday, December 1st, Mark Andrew Sherman sold 4,500 shares of Dolby Laboratories stock. The shares were sold at an average price of $67.56, for a total value of $304,020.00.

Dolby Laboratories Price Performance

NYSE:DLB traded up $0.02 during trading hours on Thursday, reaching $67.16. 45,626 shares of the company traded hands, compared to its average volume of 469,275. The firm's 50-day moving average is $66.88 and its 200-day moving average is $71.25. The stock has a market cap of $6.41 billion, a P/E ratio of 25.47 and a beta of 0.89. Dolby Laboratories has a 1-year low of $64.02 and a 1-year high of $89.66.

Dolby Laboratories (NYSE:DLB - Get Free Report) last posted its quarterly earnings data on Tuesday, November 18th. The electronics maker reported $0.99 EPS for the quarter, topping analysts' consensus estimates of $0.70 by $0.29. The firm had revenue of $307.02 million during the quarter, compared to analysts' expectations of $305.76 million. Dolby Laboratories had a return on equity of 11.99% and a net margin of 18.90%.During the same quarter last year, the business posted $0.61 EPS. The firm's quarterly revenue was up .7% compared to the same quarter last year. Dolby Laboratories has set its FY 2026 guidance at 4.190-4.340 EPS and its Q1 2026 guidance at 0.790-0.940 EPS. As a group, research analysts predict that Dolby Laboratories will post 2.94 earnings per share for the current year.

Dolby Laboratories Increases Dividend

The company also recently announced a quarterly dividend, which was paid on Wednesday, December 10th. Shareholders of record on Tuesday, December 2nd were paid a $0.36 dividend. This represents a $1.44 annualized dividend and a yield of 2.1%. The ex-dividend date of this dividend was Tuesday, December 2nd. This is an increase from Dolby Laboratories's previous quarterly dividend of $0.33. Dolby Laboratories's dividend payout ratio is presently 54.75%.

Analyst Ratings Changes

Several research analysts have weighed in on the company. Rosenblatt Securities cut their price target on Dolby Laboratories from $95.00 to $85.00 and set a "buy" rating for the company in a report on Wednesday, November 19th. Barrington Research reduced their target price on Dolby Laboratories from $100.00 to $95.00 and set an "outperform" rating on the stock in a research report on Wednesday, November 19th. Baird R W raised Dolby Laboratories to a "hold" rating in a research note on Friday, September 5th. Robert W. Baird started coverage on shares of Dolby Laboratories in a research note on Friday, September 5th. They set a "neutral" rating and a $74.00 price objective for the company. Finally, Weiss Ratings reissued a "hold (c-)" rating on shares of Dolby Laboratories in a research report on Monday. Three research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and an average price target of $92.00.

Read Our Latest Stock Report on DLB

Institutional Trading of Dolby Laboratories

A number of institutional investors and hedge funds have recently bought and sold shares of the business. Boothbay Fund Management LLC boosted its stake in shares of Dolby Laboratories by 4.1% during the 2nd quarter. Boothbay Fund Management LLC now owns 4,020 shares of the electronics maker's stock worth $299,000 after acquiring an additional 157 shares in the last quarter. MAI Capital Management raised its position in shares of Dolby Laboratories by 87.1% during the first quarter. MAI Capital Management now owns 348 shares of the electronics maker's stock worth $28,000 after purchasing an additional 162 shares during the period. Mitchell & Pahl Private Wealth LLC lifted its holdings in shares of Dolby Laboratories by 1.1% during the third quarter. Mitchell & Pahl Private Wealth LLC now owns 15,733 shares of the electronics maker's stock valued at $1,139,000 after purchasing an additional 170 shares during the last quarter. Equitable Trust Co. boosted its position in shares of Dolby Laboratories by 3.3% in the 2nd quarter. Equitable Trust Co. now owns 5,567 shares of the electronics maker's stock valued at $413,000 after purchasing an additional 177 shares during the period. Finally, Steward Partners Investment Advisory LLC increased its stake in Dolby Laboratories by 13.9% in the 2nd quarter. Steward Partners Investment Advisory LLC now owns 1,587 shares of the electronics maker's stock worth $118,000 after purchasing an additional 194 shares in the last quarter. Institutional investors and hedge funds own 58.56% of the company's stock.

Dolby Laboratories Company Profile

(Get Free Report)

Dolby Laboratories, Inc creates audio and imaging technologies that transform entertainment at the cinema, DTV transmissions and devices, mobile devices, OTT video and music services, home entertainment devices, and automobiles. The company develops and licenses its audio technologies, such as AAC & HE-AAC, a digital audio codec solution used for a range of media applications; AVC, a digital video codec with high bandwidth efficiency used in various media devices; Dolby AC-4, a digital audio coding technology that delivers new audio experiences to a range of playback devices; and Dolby Atmos technology for cinema and various media devices.